However, these results are still reportable given the current validated work in the field and our correlation with the larger Beat AML dataset confirming HLA-E presence in AHR high samples, MHC class I/II and NK cell receptor-ligand differences. This evidence concerns the gene HLA-E and acute myeloid leukemia.